Efficacy of Brentuximab Vedotin and Nivolumab in Refractory or Relapsed Hodgkin Lymphoma: A Systematic Review

Systematic review examined nivolumab combined with brentuximab vedotin for treatment of relapsed Hodgkin lymphoma.